SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hassan Farhat, Oumedaly Reman, Emmanuel Raffoux, Celine Berthon, Cécile Pautas, Leila Kammoun, Sylvain Chantepie, Claude Gardin, Philippe Rousselot, Sylvie Chevret, Hervé Dombret, Sylvie Castaigne, Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association, American Journal of Hematology, 2012, 87, 1
  2. 2
    A Renneville, N Boissel, O Nibourel, C Berthon, N Helevaut, C Gardin, J-M Cayuela, S Hayette, O Reman, N Contentin, D Bordessoule, C Pautas, S de Botton, T de Revel, C Terre, P Fenaux, X Thomas, S Castaigne, H Dombret, C Preudhomme, Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association, Leukemia, 2012,

    CrossRef

  3. 3
    Xi Chen, Yongchen Yang, Yi Huang, Junjie Tan, Yuanyuan Chen, Jing Yang, Hu Dou, Lin Zou, Jie Yu, Liming Bao, WT1mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population, Leukemia & Lymphoma, 2012, 1

    CrossRef

  4. 4
    David Grimwade, Krzysztof Mrózek, Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia, Hematology/Oncology Clinics of North America, 2011, 25, 6, 1135

    CrossRef

  5. 5
    Naveen Pemmaraju, Hagop Kantarjian, Farhad Ravandi, Jorge Cortes, FLT3 inhibitors in the treatment of acute myeloid leukemia, Cancer, 2011, 117, 15
  6. 6
    Phoenix A. Ho, Matthew A. Kutny, Todd A. Alonzo, Robert B. Gerbing, Jason Joaquin, Susana C. Raimondi, Alan S. Gamis, Soheil Meshinchi, Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group, Pediatric Blood & Cancer, 2011, 57, 2
  7. 7
    Firoz Ahmad, Wilma D'Souza, Swarna Mandava, Bibhu Ranjan Das, Molecular analysis ofWT1andKITmutations in patients from an Indian population withde novoacute myeloid leukemia: determination of incidence, distribution patterns, and report of a novelKITmutation, Leukemia & Lymphoma, 2011, 52, 5, 865

    CrossRef

  8. 8
    Yunsuk Choi, Je-Hwan Lee, Eun-Hye Hur, Mun Jung Kang, Sung-Doo Kim, Jung-Hee Lee, Dae-Young Kim, Sung-Nam Lim, Kyun-Seop Bae, Hyeong-Seok Lim, Miee Seol, Young-A Kang, Kyoo-Hyung Lee, Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia, Annals of Hematology, 2011, 91, 5, 671

    CrossRef

  9. 9
    A Renneville, N Boissel, N Helevaut, O Nibourel, C Terré, C Pautas, C Gardin, X Thomas, P Turlure, O Reman, C Berthon, H Dombret, S Castaigne, C Preudhomme, Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia, Leukemia, 2011, 25, 12, 1918

    CrossRef

  10. 10
    Ulrike Bacher, Susanne Schnittger, Torsten Haferlach, Molecular genetics in acute myeloid leukemia, Current Opinion in Oncology, 2010, 22, 6, 646

    CrossRef

  11. 11
    H. Becker, G. Marcucci, K. Maharry, M. D. Radmacher, K. Mrozek, D. Margeson, S. P. Whitman, P. Paschka, K. B. Holland, S. Schwind, Y.-Z. Wu, B. L. Powell, T. H. Carter, J. E. Kolitz, M. Wetzler, A. J. Carroll, M. R. Baer, J. O. Moore, M. A. Caligiuri, R. A. Larson, C. D. Bloomfield, Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, Blood, 2010, 116, 5, 788

    CrossRef

  12. 12
    Karen WL Yee, Armand Keating, Older patients with acute myeloid leukemia, Expert Review of Hematology, 2010, 3, 6, 755

    CrossRef

  13. 13
    P. A. Ho, R. Zeng, T. A. Alonzo, R. B. Gerbing, K. L. Miller, J. A. Pollard, D. L. Stirewalt, N. A. Heerema, S. C. Raimondi, B. Hirsch, J. L. Franklin, B. Lange, S. Meshinchi, Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group, Blood, 2010, 116, 5, 702

    CrossRef

  14. 14
    Carolyn Owen, Jude Fitzgibbon, Peter Paschka, The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia, Hematological Oncology, 2010, 28, 1
  15. 15
    H.-A. Hou, T.-C. Huang, L.-I. Lin, C.-Y. Liu, C.-Y. Chen, W.-C. Chou, J.-L. Tang, M.-H. Tseng, C.-F. Huang, Y.-C. Chiang, F.-Y. Lee, M.-C. Liu, M. Yao, S.-Y. Huang, B.-S. Ko, S.-C. Hsu, S.-J. Wu, W. Tsay, Y.-C. Chen, H.-F. Tien, WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system, Blood, 2010, 115, 25, 5222

    CrossRef

  16. 16
    H. Dohner, E. H. Estey, S. Amadori, F. R. Appelbaum, T. Buchner, A. K. Burnett, H. Dombret, P. Fenaux, D. Grimwade, R. A. Larson, F. Lo-Coco, T. Naoe, D. Niederwieser, G. J. Ossenkoppele, M. A. Sanz, J. Sierra, M. S. Tallman, B. Lowenberg, C. D. Bloomfield, Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, 2009, 115, 3, 453

    CrossRef

  17. 17
    D. Grimwade, R. K. Hills, Independent prognostic factors for AML outcome, Hematology, 2009, 2009, 1, 385

    CrossRef

  18. 18
    A Renneville, S Kaltenbach, E Clappier, S Collette, J-B Micol, B Nelken, P Lepelley, N Dastugue, Y Benoît, Y Bertrand, C Preudhomme, H Cavé, Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies, Leukemia, 2009, 24, 2, 476

    CrossRef